Related Experiment Videos
[Lipotropins (beta- and gamma-LPH). Valid indicators of corticotropic function]
Annales D'Endocrinologie
|January 1, 1984
Summary
Lipoprotein hormone (LPH) offers a stable and reliable marker for corticotropic function, outperforming adrenocorticotropic hormone (ACTH) in diagnostic accuracy, especially in adrenal insufficiency.
Area of Science:
- Endocrinology
- Biochemistry
Background:
- Adrenocorticotropic hormone (ACTH) and lipotropic hormone (LPH) share a common precursor.
- Assessing corticotropic function relies on measuring these hormones.
Purpose of the Study:
- To evaluate LPH as a superior marker for corticotropic function compared to ACTH.
- To investigate the stability and diagnostic utility of LPH plasma levels.
Main Methods:
- Simultaneous measurement of plasma ACTH and LPH levels in control subjects and patients.
- Assessment under basal conditions and after dynamic corticotropic axis stimulation.
- Evaluation of LPH stability in blood ex vivo and its renal clearance.
Main Results:
- Established normal basal plasma levels for ACTH and LPH, confirming parallel secretion.
- Demonstrated LPH stability in blood at room temperature, unlike ACTH.
- Identified the kidney as the primary site of LPH catabolism.
- Showcased the diagnostic value of LPH in primary adrenal insufficiency and corticotropic deficiency.
Conclusions:
- Plasma LPH levels provide a reliable index of corticotropic function, except in specific dissociation scenarios.
- LPH determination offers advantages over ACTH measurement due to its stability and diagnostic utility.